إعلان
إعلان

ORMP

ORMP logo

Oramed Pharmaceuticals Inc.

2.91
USD
برعاية
+0.06
+2.18%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

2.99

+0.08
+2.68%

تقارير أرباح ORMP

النسبة الإيجابية المفاجئة

ORMP تفوق 11 من 15 آخر التقديرات.

73%

التقرير التالي

الاسبوع القادم
بيانات التقرير القادم
٠٨ يناير ٢٠٢٦
Estimate for Q1 26 (Revenue/ EPS)
--
/
--
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q1 25 (Revenue/ EPS)
--
/
--

Oramed Pharmaceuticals Inc. earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, ORMP reported earnings of 1.12 USD per share (EPS) for Q3 25, beating the estimate of -0.04 USD, resulting in a 2845.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.92% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Oramed Pharmaceuticals Inc. reported EPS of $1.12, beating estimates by 2845.1%, and revenue of $0.00, 0% as expectations.
The stock price moved down -2.92%, changed from $2.40 before the earnings release to $2.33 the day after.
The next earning report is scheduled for ٠٨ يناير ٢٠٢٦.
Based on -- analysts, Oramed Pharmaceuticals Inc. is expected to report EPS of -- and revenue of -- for Q1 2026.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان